| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform
|
Liu, Rong
|
|
2016
|
19 |
1 |
p. 82-91
|
artikel
|
| 2 |
Application of Item Response Theory to Modeling of Expanded Disability Status Scale in Multiple Sclerosis
|
Novakovic, A. M.
|
|
2016
|
19 |
1 |
p. 172-179
|
artikel
|
| 3 |
Bone Regeneration Using Gene-Activated Matrices
|
D’Mello, Sheetal
|
|
2016
|
19 |
1 |
p. 43-53
|
artikel
|
| 4 |
Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy
|
Mahran, Rama I.
|
|
2016
|
19 |
1 |
p. 54-81
|
artikel
|
| 5 |
Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug–Drug Interactions and Co-medication Regimens
|
Moj, Daniel
|
|
2016
|
19 |
1 |
p. 298-312
|
artikel
|
| 6 |
Commentary on “Statistical Approaches to Assess Biosimilarity from Analytical Data” by Burdick et al[1]
|
Tsong, Yi
|
|
2016
|
19 |
1 |
p. 15-17
|
artikel
|
| 7 |
Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®
|
Marini, Joseph C.
|
|
2016
|
19 |
1 |
p. 161-171
|
artikel
|
| 8 |
Development and Translational Application of an Integrated, Mechanistic Model of Antibody-Drug Conjugate Pharmacokinetics
|
Sukumaran, Siddharth
|
|
2016
|
19 |
1 |
p. 130-140
|
artikel
|
| 9 |
Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes
|
Yuan, Wenmin
|
|
2016
|
19 |
1 |
p. 150-160
|
artikel
|
| 10 |
Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules
|
Maher, Sam
|
|
2016
|
19 |
1 |
p. 244-253
|
artikel
|
| 11 |
Early Development Challenges for Drug Products Containing Nanomaterials
|
Grossman, Jennifer H.
|
|
2016
|
19 |
1 |
p. 92-102
|
artikel
|
| 12 |
Further Evaluation of Covariate Analysis using Empirical Bayes Estimates in Population Pharmacokinetics: the Perception of Shrinkage and Likelihood Ratio Test
|
Xu, Xu Steven
|
|
2016
|
19 |
1 |
p. 264-273
|
artikel
|
| 13 |
Inkjet Printing of Proteins: an Experimental Approach
|
Montenegro-Nicolini, Miguel
|
|
2016
|
19 |
1 |
p. 234-243
|
artikel
|
| 14 |
Intra-articular Injection of Urinary Bladder Matrix Reduces Osteoarthritis Development
|
Jacobs, Heather N.
|
|
2016
|
19 |
1 |
p. 141-149
|
artikel
|
| 15 |
Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn’s Disease Is Determined by Their Concentration
|
Edlund, Helena
|
|
2016
|
19 |
1 |
p. 223-233
|
artikel
|
| 16 |
Mechanistic Evaluation of Hydration Effects on the Human Epidermal Permeation of Salicylate Esters
|
Yousef, Shereen
|
|
2016
|
19 |
1 |
p. 180-190
|
artikel
|
| 17 |
Mitigation of Pre-existing Antibodies to a Biotherapeutic in Non-clinical Species When Establishing Anti-drug Antibody Assay Cutpoint
|
Kumar, Seema C
|
|
2016
|
19 |
1 |
p. 313-319
|
artikel
|
| 18 |
Nanomaterial Drug Products: Manufacturing and Analytical Perspectives
|
Sayes, Christie M.
|
|
2016
|
19 |
1 |
p. 18-25
|
artikel
|
| 19 |
Particle Characterization for a Protein Drug Product Stored in Pre-Filled Syringes Using Micro-Flow Imaging, Archimedes, and Quartz Crystal Microbalance with Dissipation
|
Zheng, Songyan
|
|
2016
|
19 |
1 |
p. 110-116
|
artikel
|
| 20 |
Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients
|
Dubinsky, Marla C.
|
|
2016
|
19 |
1 |
p. 215-222
|
artikel
|
| 21 |
Pharmacokinetic Modeling and Monte Carlo Simulation to Predict Interindividual Variability in Human Exposure to Oseltamivir and Its Active Metabolite, Ro 64-0802
|
Ito, Mototsugu
|
|
2016
|
19 |
1 |
p. 286-297
|
artikel
|
| 22 |
Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles
|
Li, Min
|
|
2016
|
19 |
1 |
p. 26-42
|
artikel
|
| 23 |
Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis
|
Zhong, Shilong
|
|
2016
|
19 |
1 |
p. 203-214
|
artikel
|
| 24 |
Revealing the Neuroendocrine Response After Remoxipride Treatment Using Multi-Biomarker Discovery and Quantifying It by PK/PD Modeling
|
Brink, Willem J. van den
|
|
2016
|
19 |
1 |
p. 274-285
|
artikel
|
| 25 |
Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin
|
Mazor, Ronit
|
|
2016
|
19 |
1 |
p. 117-129
|
artikel
|
| 26 |
Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin
|
Mazor, Ronit
|
|
|
19 |
1 |
p. 117-129
|
artikel
|
| 27 |
Specific Immune Response to Phospholipase B-Like 2 Protein, a Host Cell Impurity in Lebrikizumab Clinical Material
|
Fischer, Saloumeh Kadkhodayan
|
|
2016
|
19 |
1 |
p. 254-263
|
artikel
|
| 28 |
Statistical Approaches to Assess Biosimilarity from Analytical Data
|
Burdick, Richard
|
|
2016
|
19 |
1 |
p. 4-14
|
artikel
|
| 29 |
The Delivery of High-Dose Dry Powder Antibiotics by a Low-Cost Generic Inhaler
|
Parumasivam, Thaigarajan
|
|
2016
|
19 |
1 |
p. 191-202
|
artikel
|
| 30 |
The Effect of Polymorphism on Surface Energetics of D-Mannitol Polymorphs
|
Smith, Robert R.
|
|
2016
|
19 |
1 |
p. 103-109
|
artikel
|
| 31 |
The Selection and Control of Starting Materials Should be Governed by Science and Risk-Based Approaches
|
Watson, Timothy J. N.
|
|
2016
|
19 |
1 |
p. 1-3
|
artikel
|
Tijdschrift beschrijving